Cotherabio
San Mateo, US · 1 known investors
Cothera Bioscience is a clinical-stage biotech company developing cancer therapeutics aimed at previously undruggable oncology targets, using a translational platform based on synthetic lethality and protein degradation pathways. Its lead candidate is zotiraciclib, an oral CDK9 inhibitor for recurrent high-grade glioma with IDH1/2 mutations.
Investors · 1
Frequently asked questions
- What does Cotherabio do?
- Cothera Bioscience is a clinical-stage biotech company developing cancer therapeutics aimed at previously undruggable oncology targets, using a translational platform based on synthetic lethality and protein degradation pathways. Its lead candidate is zotiraciclib, an oral CDK9 inhibitor for recurrent high-grade glioma with IDH1/2 mutations.
- Who are Cotherabio's investors?
- Cotherabio's investors include Pan-Lin Capital.
- Where is Cotherabio headquartered?
- Cotherabio is headquartered in San Mateo, US.